Download PDF
Thromb Haemost 2016; 116(04): 772-774
DOI: 10.1160/TH16-05-0362
Letter to the Editor
Schattauer GmbH

Recommendation for ISTH/SSC Criterion 2015 for autoimmune acquired factor XIII/13 deficiency

Akitada Ichinose
1   Department of Molecular Patho-Biochemistry, Yamagata University School of Medicine, Yamagata, Japan
,
Hans P. Kohler
2   Experimental Haemostasis Group, Department of Clinical Research, University of Bern, and Department of Internal Medicine, Tiefenauspital, Inselgruppe AG, Switzerland
,
Helen Philippou
3   Section on Mechanisms of Thrombosis, Leeds Institute for Health, Genetics and Therapeutics, University of Leeds, Leeds, UK
› Author Affiliations
Further Information

Publication History

Received: 11 May 2016

Accepted after minor revision: 22 June 2016

Publication Date:
02 December 2017 (online)

Also available at
    Permissions and Reprints

Supplementary Material to this article is available online at www.thrombosis-online.com.

 

  • References

  • 1 Ichinose A.. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37: 382-388.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Lorand L.. Acquired Inhibitors of Fibrin Stabilization: A Class of Hemorrhagic Disorders of Diverse Origins. In: Green D. ed. Anticoagulants Physiologic, Pathologic, and Pharmacologic. CRC Press; 1994: 169-191.
    Google Scholar
  • 3 Egbring R, Kröniger A, Seitz R.. Erworbene inhibitoren gegen Faktor XIII.. Hamostaseologie 1996; 16: 174-179.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Ichinose A. Japanese Collaborative Research Group (JCRG) on AH13 Hemorrhagic Acquired Coagulopathies. Inhibitors of Factor XIII/13 in older patients. Semin Thromb Hemost 2014; 40: 704-711.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Souri M, Osaki T, Ichinose A.. Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2B2 assembly and steal FXIII-A from native FXIII-A2B2. J Thromb Haemost 2015; 13: 802-814.
    CrossrefPubMedGoogle Scholar
  • 6 Rodeghiero F, Tosetto A, Abshire T. et al. ISTH/ SSC joint VWF and Perinatal/Pediatric Hemostasis Subcommittees Working Group. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost 2010; 08: 2063-2065.
    CrossrefPubMedGoogle Scholar
  • 7 Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 03: 692-694.
    CrossrefPubMedGoogle Scholar
  • 8 Baudo F, Collins P, Huth-Kühne A. et al. EACH2 registry contributors. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120: 39-46.
    CrossrefPubMedGoogle Scholar
  • 9 Kohler HP, Ichinose A, Seitz R. et al. on behalf of the Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 09: 1404-1406.
    CrossrefPubMedGoogle Scholar
  • 10 Huth-Kühne A, Baudo F, Collins P. et al International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009; 94: 566-575.
    CrossrefPubMedGoogle Scholar